Supplementary Figure S9 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
Year: 2025
Type: supplementary-materials
Abstract: Increase in CD99 with FFRT determined using flow cytometry and western blotting. Blocking CD99 with 10D1, followed by FFRT, enhances the therapeutic impact of IT-delivered 10D1 in DMG, as shown by BLI images showing a reduction in tumor burden and increased body weight. CBC analysis showed no apparent toxicity due to this treatment protocol.
Authors: Ilango Balakrishnan, Krishna Madhavan, Angela Pierce, Joshua Michlin, Breauna Brunt, Senthilnath Lakshmanachetty, Dong Wang, John DeSisto, Zachary James Nuss, Nathan Davidson, Faye Walker, Ammu Suresh, Andrew Donson, Bridget Sanford, Kenneth L. Jones, Etienne P. Danis, Siddhartha S. Mitra, Adam L. Green, Nathan Dahl, Rajeev Vibhakar, Sujatha Venkataraman
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4413380813